This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2e1q

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2e1q.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2e1q.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2e1q| PDB=2e1q | SCENE= }}
{{STRUCTURE_2e1q| PDB=2e1q | SCENE= }}
-
'''Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val'''
+
===Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val===
-
==Overview==
+
<!--
-
Xanthine oxidase (oxidoreductase; XOR) and aldehyde oxidase (AO) are similar in protein structure and prosthetic group composition, but differ in substrate preference. Here we show that mutation of two amino acid residues in the active site of human XOR for purine substrates results in conversion of the substrate preference to AO type. Human XOR and its Glu803-to-valine (E803V) and Arg881-to-methionine (R881M) mutants were expressed in an Escherichia coli system. The E803V mutation almost completely abrogated the activity towards hypoxanthine as a substrate, but very weak activity towards xanthine remained. On the other hand, the R881M mutant lacked activity towards xanthine, but retained slight activity towards hypoxanthine. Both mutants, however, exhibited significant aldehyde oxidase activity. The crystal structure of E803V mutant of human XOR was determined at 2.6 A resolution. The overall molybdopterin domain structure of this mutant closely resembles that of bovine milk XOR; amino acid residues in the active centre pocket are situated at very similar positions and in similar orientations, except that Glu803 was replaced by valine, indicating that the decrease in activity towards purine substrate is not due to large conformational change in the mutant enzyme. Unlike wild-type XOR, the mutants were not subject to time-dependent inhibition by allopurinol.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17301077}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17301077 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17301077}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Oxidoreductase]]
[[Category: Oxidoreductase]]
[[Category: Xanthine oxidase]]
[[Category: Xanthine oxidase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 01:45:40 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:30:53 2008''

Revision as of 02:30, 28 July 2008

Image:2e1q.png

Template:STRUCTURE 2e1q

Crystal Structure of Human Xanthine Oxidoreductase mutant, Glu803Val

Template:ABSTRACT PUBMED 17301077

About this Structure

2E1Q is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate., Yamaguchi Y, Matsumura T, Ichida K, Okamoto K, Nishino T, J Biochem. 2007 Apr;141(4):513-24. Epub 2007 Feb 14. PMID:17301077

Page seeded by OCA on Mon Jul 28 05:30:53 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2e1q"
Personal tools